Literature DB >> 6291392

Amniotic fluid beta-endorphin and alpha-melanocyte--stimulating hormone immunoreactivity in normal and complicated pregnancies.

W A Divers, R D Stewart, M M Wilkes, S S Yen.   

Abstract

beta-Endorphin (beta-EP) and alpha-melanocyte--stimulating hormone (alpha-MSH) are members of a family of peptides which are found in the intermediate lobe of the fetal pituitary gland and placenta. In the present study, concentrations of immunoreactive beta-EP (i beta-EP) and alpha-MSH were determined by radioimmunoassay in the amniotic fluid compartment of both normal (n = 72) and complicated (n = 44) pregnancies. In normal pregnancies, there was a significant (p less than 0.05) fall in the mean amniotic fluid i beta-EP from the second to third trimester (from 175 to 132 pg/ml). A similar, but not statistically significant, decline in the mean amniotic fluid concentrations of alpha-MSH (from 46 to 34 pg/ml) was also noted. Concentrations of amniotic fluid i beta-EP showed a significant correlation with alpha-MSH (r = 0.61, p less than 0.001). Significant elevations of mean amniotic fluid i beta-EP but not alpha-MSH were found in pregnancies complicated by intrauterine growth retardation (215 pg/ml, p less than 0.001) and premature labor (225 pg/ml, p less than 0.001). Our findings suggest that levels of i beta-EP and alpha-MSH in amniotic fluid decrease from the second to the third trimester of pregnancy, and that elevation in i beta-EP concentration in amniotic fluid, in all probability, reflects the secretion of beta-EP by the fetus in response to fetal distress.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6291392     DOI: 10.1016/0002-9378(82)90223-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  1 in total

1.  Des-acetyl-alpha-MSH and not alpha-MSH is the major form of alpha-MSH in amniotic fluid.

Authors:  A Mauri; A Argiolas; M R Melis; L Lai; W Fratta; A Caruso; A Lanzone; F Serri; F Caminiti; S Mancuso
Journal:  J Endocrinol Invest       Date:  1988-05       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.